Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 5
Submit an article Journal homepage
198
Views
14
CrossRef citations to date
0
Altmetric
Letter

Clinical experience with the heat shock protein-90 inhibitor, tanespimycin, in patients with relapsed lymphoma

Yasuhiro OkiDepartment of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Amanda CopelandDepartment of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Jorge RomagueraDepartment of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Luis FayadDepartment of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Michelle FanaleDepartment of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Silvana de Castro FariaDepartment of Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
L. Jeffrey MedeirosDepartment of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Percy IvyInvestigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD, USA
&
Anas YounesDepartment of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
 show all
Pages 990-992 | Received 03 Aug 2011, Accepted 08 Oct 2011, Published online: 13 Mar 2012
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Acknowledgements

This study was supported by an NCI grant 5 R21 CA117070-02 and by the Prince Fund for Lymphoma Clinical and Translational Research to A.Y.

Potential conflict of interest:

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.